ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 133 filers reported holding ARCUS BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $75,390,431 | -14.5% | 4,200,024 | -3.3% | 0.00% | -20.0% |
Q2 2023 | $88,191,057 | -12.0% | 4,342,248 | -21.0% | 0.01% | -16.7% |
Q1 2023 | $100,251,248 | -31.6% | 5,496,253 | -22.5% | 0.01% | +50.0% |
Q4 2022 | $146,591,544 | +35.3% | 7,088,566 | +71.1% | 0.00% | -42.9% |
Q3 2022 | $108,356,000 | -3.6% | 4,142,060 | -6.6% | 0.01% | 0.0% |
Q2 2022 | $112,404,000 | +29.5% | 4,435,849 | +61.3% | 0.01% | +75.0% |
Q1 2022 | $86,787,000 | -2.2% | 2,749,919 | +25.5% | 0.00% | 0.0% |
Q4 2021 | $88,707,000 | +9.1% | 2,191,931 | -6.0% | 0.00% | 0.0% |
Q3 2021 | $81,304,000 | +10.2% | 2,331,630 | -13.2% | 0.00% | 0.0% |
Q2 2021 | $73,749,000 | +21.3% | 2,685,701 | +24.0% | 0.00% | +33.3% |
Q1 2021 | $60,804,000 | +28.5% | 2,165,394 | +18.8% | 0.00% | 0.0% |
Q4 2020 | $47,321,000 | +9.6% | 1,822,855 | -27.6% | 0.00% | 0.0% |
Q3 2020 | $43,167,000 | +9.9% | 2,518,468 | +58.6% | 0.00% | 0.0% |
Q2 2020 | $39,275,000 | +339.7% | 1,587,499 | +146.7% | 0.00% | +200.0% |
Q1 2020 | $8,932,000 | +38.1% | 643,537 | +0.5% | 0.00% | – |
Q4 2019 | $6,469,000 | +15.2% | 640,467 | +3.8% | 0.00% | – |
Q3 2019 | $5,617,000 | +15.6% | 617,246 | +1.0% | 0.00% | – |
Q2 2019 | $4,858,000 | -28.2% | 611,113 | +12.9% | 0.00% | -100.0% |
Q1 2019 | $6,762,000 | +23.1% | 541,375 | +6.1% | 0.00% | 0.0% |
Q4 2018 | $5,495,000 | +338.9% | 510,243 | +467.8% | 0.00% | – |
Q3 2018 | $1,252,000 | +58.1% | 89,862 | +38.9% | 0.00% | – |
Q2 2018 | $792,000 | – | 64,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |